Polymorphism of ␣2 integrin (C807T) is shown to be associated with an increased incidence of thrombotic cardiovascular events. However, it is not clear whether this polymorphism is associated with atherosclerotic arterial wall thickening. In this study, we examined the association of C807T polymorphism with arterial wall thickness in 265 control subjects and 272 patients with type 2 diabetes. In all subjects, intima-media thickness of the right carotid artery in the 807TT group (0.649 ؎ 0.028 mm [SE]) was significantly (P ؍ 0.0228, Scheffe's F test) less than in the 807CC group (0.767 ؎ 0.033). This effect of polymorphism is gene dose dependent (P ؍ 0.0227, ANOVA). The similar association was also observed in patients with diabetes but not in control subjects. Multiple regression analysis in all subjects revealed that the T allele was inversely ( ؍ ؊0.095, P ؍ 0.021) associated with intima-media thickness independent of age, HbA 1c , and HDL cholesterol. Finally, an inverse relation between the occurrence of carotid plaque and the T allele was observed in patients with diabetes with an adjusted odds ratio of 0.487 (P ؍ 0.031) in multiple logistic regression analyses. These results suggest that the number of 807T alleles in ␣2 integrin is protective against atherosclerotic arterial wall thickening and the occurrence of plaque in patients with type 2 diabetes. Diabetes 51:1523-1528, 2002 P rogression of atherosclerosis is known to be related to vascular risk factors such as hypertension, smoking, diabetes, and high cholesterol levels. In addition to these conventional risk factors, genetic predispositions may enhance the risk of cardiovascular events (reviewed in Murata et al. [1]). Initially reported was the relation between a polymorphism of ACE and coronary arterial diseases (2). Other possible genetic risk factors include angiotensin II type I receptor, endothelial nitric oxide synthase, apolipoprotein E, lipoprotein lipase, paraoxonase, methylenetetrahydrofolate reductase, fibrinogen, plasminogen activator inhibitor-1, thrombomodulin, and platelet glycoproteins (GPs; see review [1]).The platelet membrane ␣21 integrin, also known as GP Ia-IIa, serves as a platelet receptor for collagen (3). It mediates platelet primary adhesion to subendothelial tissues and activation (4,5). The gene encoding ␣2 integrin has at least eight polymorphisms, including two silent polymorphisms located within the intron (6). C807T (224Phe) and G873A (246Thr) were reported to be in linkage and associated with the expression density of GP Ia-IIa on the platelet surface (7). T807/A873 is associated with a higher expression of the receptor, and C807/G873 is associated with a lower expression density. The expression density of ␣2 integrin was also shown to be associated with the rate of platelet attachment to type I collagen, even under high shear rates (8).␣21 integrin is also expressed in vascular endothelium (9 -11). In endothelial cells, ␣21 integrin seems to function as a receptor for laminin as well as collagen (12), ...